Supawat Thongthip
Stock Analyst at Truist Financial
(0.24)
# 4,662
Out of 5,119 analysts
19
Total ratings
18.8%
Success rate
-24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Supawat Thongthip
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Reiterated: Buy | $26 → $27 | $17.63 | +53.15% | 4 | Nov 6, 2026 | |
| AVBP ArriVent BioPharma | Reiterated: Buy | $18 → $21 | $13.64 | +53.96% | 3 | Oct 27, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Buy | $40 → $41 | $18.28 | +124.29% | 6 | Oct 21, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $50 | $9.62 | +419.75% | 3 | Aug 13, 2026 | |
| IMNM Immunome | Reiterated: Buy | $38 | $18.71 | +103.10% | 3 | Aug 12, 2026 |
Janux Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $26 → $27
Current: $17.63
Upside: +53.15%
ArriVent BioPharma
Oct 27, 2026
Reiterated: Buy
Price Target: $18 → $21
Current: $13.64
Upside: +53.96%
Arcus Biosciences
Oct 21, 2026
Reiterated: Buy
Price Target: $40 → $41
Current: $18.28
Upside: +124.29%
Sutro Biopharma
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $9.62
Upside: +419.75%
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $38
Current: $18.71
Upside: +103.10%